Published in Int J Radiat Oncol Biol Phys on October 26, 2005
Parotid glands dose-effect relationships based on their actually delivered doses: implications for adaptive replanning in radiation therapy of head-and-neck cancer. Int J Radiat Oncol Biol Phys (2013) 2.19
Adaptive radiotherapy for head-and-neck cancer: initial clinical outcomes from a prospective trial. Int J Radiat Oncol Biol Phys (2011) 1.59
Adaptive radiation therapy for head and neck cancer-can an old goal evolve into a new standard? J Oncol (2010) 1.41
Measurement of eye lens dose for Varian On-Board Imaging with different cone-beam computed tomography acquisition techniques. J Med Phys (2016) 1.37
Correction of patient positioning errors based on in-line cone beam CTs: clinical implementation and first experiences. Radiat Oncol (2006) 1.21
Use of kilovoltage X-ray volume imaging in patient dose calculation for head-and-neck and partial brain radiation therapy. Radiat Oncol (2010) 1.10
Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer. Radiother Oncol (2011) 1.07
Systematic evaluation of three different commercial software solutions for automatic segmentation for adaptive therapy in head-and-neck, prostate and pleural cancer. Radiat Oncol (2012) 0.98
Recent advances in image-guided radiotherapy for head and neck carcinoma. J Oncol (2009) 0.96
Predictors for replanning in loco-regionally advanced nasopharyngeal carcinoma patients undergoing intensity-modulated radiation therapy: a prospective observational study. BMC Cancer (2013) 0.93
Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group. Radiat Oncol (2014) 0.88
Technical note: DIRART--A software suite for deformable image registration and adaptive radiotherapy research. Med Phys (2011) 0.88
Dosimetric variations of target volumes and organs at risk in nasopharyngeal carcinoma intensity-modulated radiotherapy. Br J Radiol (2011) 0.87
Assessment of anatomical and dosimetric changes by a deformable registration method during the course of intensity-modulated radiotherapy for nasopharyngeal carcinoma. J Radiat Res (2013) 0.87
Developing an adaptive radiation therapy strategy for nasopharyngeal carcinoma. J Radiat Res (2013) 0.86
Impact of head and neck cancer adaptive radiotherapy to spare the parotid glands and decrease the risk of xerostomia. Radiat Oncol (2015) 0.85
Evaluation of deformable image registration methods for dose monitoring in head and neck radiotherapy. Biomed Res Int (2015) 0.84
Volumetric change of human papillomavirus-related neck lymph nodes before, during, and shortly after intensity-modulated radiation therapy. Head Neck (2012) 0.83
Target volume and position variations during intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma. Onco Targets Ther (2013) 0.83
Evaluation of an automatic segmentation algorithm for definition of head and neck organs at risk. Radiat Oncol (2014) 0.83
Impact of repeat computerized tomography replans in the radiation therapy of head and neck cancers. J Med Phys (2014) 0.83
Tomotherapy as a tool in image-guided radiation therapy (IGRT): current clinical experience and outcomes. Biomed Imaging Interv J (2007) 0.82
Impact of residual setup error on parotid gland dose in intensity-modulated radiation therapy with or without planning organ-at-risk margin. Strahlenther Onkol (2009) 0.82
Parotid gland volumetric changes during intensity-modulated radiotherapy in head and neck cancer. Br J Radiol (2012) 0.82
Image-based modeling of tumor shrinkage in head and neck radiation therapy. Med Phys (2010) 0.82
Replanning Criteria and Timing Definition for Parotid Protection-Based Adaptive Radiation Therapy in Nasopharyngeal Carcinoma. Biomed Res Int (2015) 0.81
Pattern and predictors of volumetric change of parotid glands during intensity modulated radiotherapy. Br J Radiol (2013) 0.80
A prospective analysis of factors that influence weight loss in patients undergoing radiotherapy. Chin J Cancer (2013) 0.80
Comparison of CT number calibration techniques for CBCT-based dose calculation. Strahlenther Onkol (2015) 0.80
Using neoadjuvant chemotherapy and replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma with intracranial invasion to protect critical normal tissue. Radiat Oncol (2013) 0.80
Dosimetric and geometric evaluation of the use of deformable image registration in adaptive intensity-modulated radiotherapy for head-and-neck cancer. J Radiat Res (2014) 0.79
ARCHERRT - a GPU-based and photon-electron coupled Monte Carlo dose computing engine for radiation therapy: software development and application to helical tomotherapy. Med Phys (2014) 0.79
Improving therapeutic ratio in head and neck cancer with adjuvant and cisplatin-based treatments. Biomed Res Int (2013) 0.77
Radiation-induced CT number changes in GTV and parotid glands during the course of radiation therapy for nasopharyngeal cancer. Br J Radiol (2016) 0.77
Practically acquired and modified cone-beam computed tomography images for accurate dose calculation in head and neck cancer. Strahlenther Onkol (2011) 0.77
Determining appropriate timing of adaptive radiation therapy for nasopharyngeal carcinoma during intensity-modulated radiation therapy. Radiat Oncol (2015) 0.76
IMRT and IGRT in head and neck cancer: Have we delivered what we promised? Indian J Surg Oncol (2010) 0.76
Relationship between prostate volume changes and treatment duration of neoadjuvant androgen deprivation during intensity-modulated radiation therapy for Japanese patients with prostate cancer. Nagoya J Med Sci (2016) 0.75
Methodology for Registration of Shrinkage Tumors in Head-and-Neck CT Studies. Comput Math Methods Med (2015) 0.75
Adaptive Radiotherapy for Head Neck Cancer. J Maxillofac Oral Surg (2016) 0.75
Tumor Volume Reduction Rate during Adaptive Radiation Therapy as a Prognosticator for Nasopharyngeal Cancer. Cancer Res Treat (2015) 0.75
Evaluating positional accuracy using megavoltage cone-beam computed tomography for IMRT with head-and-neck cancer. J Radiat Res (2014) 0.75
Anatomic and dosimetric changes in patients with head and neck cancer treated with an integrated MRI-tri-(60)Co teletherapy device. Br J Radiol (2016) 0.75
A case study for online plan adaptation using helical tomotherapy. J Med Phys (2012) 0.75
A dosimetric comparison of two-phase adaptive intensity-modulated radiotherapy for locally advanced nasopharyngeal cancer. J Radiat Res (2015) 0.75
Evaluating the dosimetric effect of treatment-induced changes in virally mediated head and neck cancer patients. J Med Radiat Sci (2013) 0.75
Clinical study of the time of repeated computed tomography and replanning for patients with nasopharyngeal carcinoma. Oncotarget (2017) 0.75
A modified VMAT adaptive radiotherapy for nasopharyngeal cancer patients based on CT-CT image fusion. Radiat Oncol (2013) 0.75
Strategies to optimize radiotherapy based on biological responses of tumor and normal tissue. Exp Ther Med (2012) 0.75
Rules of parotid gland dose variations and shift during intensity modulated radiation therapy for nasopharyngeal carcinoma. Radiat Oncol (2015) 0.75
Comprehensive evaluation of ten deformable image registration algorithms for contour propagation between CT and cone-beam CT images in adaptive head & neck radiotherapy. PLoS One (2017) 0.75
Adaptive Radiotherapy for Head and Neck Cancer. Technol Cancer Res Treat (2016) 0.75
A Comparative Evaluation of 3 Different Free-Form Deformable Image Registration and Contour Propagation Methods for Head and Neck MRI: The Case of Parotid Changes During Radiotherapy. Technol Cancer Res Treat (2017) 0.75
Study of Variation in Dose Calculation Accuracy Between kV Cone-Beam Computed Tomography and kV fan-Beam Computed Tomography. J Med Phys (2017) 0.75
Feasibility of offline head & neck adaptive radiotherapy using deformed planning CT electron density mapping on weekly cone beam computed tomography. Br J Radiol (2016) 0.75
Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys (2002) 5.16
IMRT commissioning: multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119. Med Phys (2009) 4.47
Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol (2009) 3.99
Guidance document on delivery, treatment planning, and clinical implementation of IMRT: report of the IMRT Subcommittee of the AAPM Radiation Therapy Committee. Med Phys (2003) 3.14
Low-dose megavoltage cone-beam CT for radiation therapy. Int J Radiat Oncol Biol Phys (2005) 2.33
Potentiating endogenous antitumor immunity to prostate cancer through combination immunotherapy with CTLA4 blockade and GM-CSF. Cancer Res (2009) 2.32
Intensity-modulated radiation therapy for head-and-neck cancer: the UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys (2003) 2.29
Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer. Int J Radiat Oncol Biol Phys (2008) 2.22
Lung dose calculation with SPECT/CT for ⁹⁰Yittrium radioembolization of liver cancer. Int J Radiat Oncol Biol Phys (2012) 2.11
Spinal cord tolerance for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys (2009) 2.08
Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer. J Clin Oncol (2004) 2.02
von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted therapy for metastatic clear cell renal cell carcinoma. J Urol (2008) 1.87
CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion. Blood (2008) 1.81
Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer. Int J Radiat Oncol Biol Phys (2006) 1.81
Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors. Hum Mol Genet (2004) 1.80
Skin toxicity due to intensity-modulated radiotherapy for head-and-neck carcinoma. Int J Radiat Oncol Biol Phys (2002) 1.76
Megavoltage cone-beam CT: system description and clinical applications. Med Dosim (2006) 1.74
Successful correction of the human beta-thalassemia major phenotype using a lentiviral vector. Blood (2004) 1.74
Implementing IMRT in clinical practice: a joint document of the American Society for Therapeutic Radiology and Oncology and the American Association of Physicists in Medicine. Int J Radiat Oncol Biol Phys (2004) 1.70
Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention. Proc Natl Acad Sci U S A (2008) 1.61
Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. Radiology (2004) 1.58
A group of genome-based biomarkers that add to a Kattan nomogram for predicting progression in men with high-risk prostate cancer. Clin Cancer Res (2009) 1.56
Staging for prostate cancer: time to incorporate pretreatment prostate-specific antigen and Gleason score? Cancer (2007) 1.54
A phase II study of fixed-dose rate gemcitabine plus low-dose cisplatin followed by consolidative chemoradiation for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys (2007) 1.53
Expression of the coxsackie adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma: potential relevance to gene therapy. Cancer Res (2002) 1.50
Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection. Cancer Res (2004) 1.50
PON gene polymorphisms and ischaemic stroke: a systematic review and meta analysis. Int J Stroke (2012) 1.49
Genotoxic potential of lineage-specific lentivirus vectors carrying the beta-globin locus control region. Mol Ther (2009) 1.46
Improved human beta-globin expression from self-inactivating lentiviral vectors carrying the chicken hypersensitive site-4 (cHS4) insulator element. Mol Ther (2007) 1.40
Prostate movement during simulation resulting from retrograde urethrogram compared with "natural" prostate movement. Int J Radiat Oncol Biol Phys (2004) 1.39
Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: prognostic features of recurrence. Int J Radiat Oncol Biol Phys (2006) 1.37
Clinical response to therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: impact of patient characteristics and Von Hippel-Lindau gene status. BJU Int (2006) 1.34
The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas. Int J Radiat Oncol Biol Phys (2003) 1.32
Determination of respiratory motion for distal esophagus cancer using four-dimensional computed tomography. Int J Radiat Oncol Biol Phys (2007) 1.32
Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: the University of California-San Francisco experience. Cancer (2008) 1.31
Local-regional recurrence after surgery without postoperative irradiation for carcinomas of the major salivary glands: implications for adjuvant therapy. Int J Radiat Oncol Biol Phys (2007) 1.31
Relationship of glioblastoma multiforme to the subventricular zone is associated with survival. Neuro Oncol (2012) 1.29
Evaluation of respiratory-induced target motion for esophageal tumors at the gastroesophageal junction. Radiother Oncol (2007) 1.23
Mechanism of reduction in titers from lentivirus vectors carrying large inserts in the 3'LTR. Mol Ther (2009) 1.22
Probabilities of radiation myelopathy specific to stereotactic body radiation therapy to guide safe practice. Int J Radiat Oncol Biol Phys (2012) 1.20
Reirradiation human spinal cord tolerance for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys (2010) 1.20
Patterns of failure after combined-modality approaches incorporating radiotherapy for sinonasal undifferentiated carcinoma of the head and neck. Int J Radiat Oncol Biol Phys (2008) 1.20
Dosimetric evaluation of automatic segmentation for adaptive IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys (2010) 1.19
Prostate-specific antigen kinetics as a measure of the biologic effect of granulocyte-macrophage colony-stimulating factor in patients with serologic progression of prostate cancer. J Clin Oncol (2003) 1.17
Hereditary nonpolyposis colorectal cancer in young colorectal cancer patients: high-risk clinic versus population-based registry. Gastroenterology (2002) 1.16
Simulated real time image guided intrafraction tracking-delivery for hypofractionated prostate IMRT. Med Phys (2008) 1.16
The effect of beam energy and number of fields on photon-based IMRT for deep-seated targets. Int J Radiat Oncol Biol Phys (2002) 1.15
Encapsulated plasmid DNA treatment for human papillomavirus 16-associated anal dysplasia: a Phase I study of ZYC101. Clin Cancer Res (2002) 1.15
Carcinomas of the paranasal sinuses and nasal cavity treated with radiotherapy at a single institution over five decades: are we making improvement? Int J Radiat Oncol Biol Phys (2007) 1.15
Low dose ketoconazole with replacement doses of hydrocortisone in patients with progressive androgen independent prostate cancer. J Urol (2002) 1.14
Does image-guided radiotherapy improve toxicity profile in whole pelvic-treated high-risk prostate cancer? Comparison between IG-IMRT and IMRT. Int J Radiat Oncol Biol Phys (2008) 1.11
Investigation of the use of MOSFET for clinical IMRT dosimetric verification. Med Phys (2002) 1.09
Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys (2006) 1.08
Phase III Trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Trial 99-13. J Clin Oncol (2006) 1.07
Adenoid cystic carcinoma of the major salivary glands treated with surgery and radiation. Laryngoscope (2005) 1.07
Phase II study of ketoconazole plus granulocyte-macrophage colony-stimulating factor for prostate cancer: effect of extent of disease on outcome. J Urol (2007) 1.07
Intensity-modulated radiation therapy for malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys (2007) 1.05
Unfaithful maintenance of methylation imprints due to loss of maternal nuclear Dnmt1 during somatic cell nuclear transfer. PLoS One (2011) 1.04
Maximal COX-2 immunostaining and clinical response to celecoxib and interferon alpha therapy in metastatic renal cell carcinoma. Cancer (2006) 1.04
Single-fraction stereotactic body radiotherapy for spinal metastases from renal cell carcinoma. J Neurosurg Spine (2012) 1.03
Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes. Int J Radiat Oncol Biol Phys (2013) 1.02
A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys (2012) 1.01
Feasibility of MR imaging/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer. Int J Radiat Oncol Biol Phys (2012) 1.00
Dose gradient near target-normal structure interface for nonisocentric CyberKnife and isocentric intensity-modulated body radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys (2010) 1.00
Detection and characterization of invasive circulating tumor cells derived from men with metastatic castration-resistant prostate cancer. Int J Cancer (2014) 1.00
Can all centers plan intensity-modulated radiotherapy (IMRT) effectively? An external audit of dosimetric comparisons between three-dimensional conformal radiotherapy and IMRT for adjuvant chemoradiation for gastric cancer. Int J Radiat Oncol Biol Phys (2008) 0.99
Patient dose considerations for routine megavoltage cone-beam CT imaging. Med Phys (2007) 0.98
Comparison of inverse planning simulated annealing and geometrical optimization for prostate high-dose-rate brachytherapy. Brachytherapy (2004) 0.98
Can positron emission tomography (PET) or PET/Computed Tomography (CT) acquired in a nontreatment position be accurately registered to a head-and-neck radiotherapy planning CT? Int J Radiat Oncol Biol Phys (2008) 0.98
Lymphoid follicles are generated in high-grade cervical dysplasia and have differing characteristics depending on HIV status. Am J Pathol (2002) 0.97
Successful treatment of high risk and recurrent pediatric desmoids using radiation as a component of multimodality therapy. Int J Radiat Oncol Biol Phys (2009) 0.97
Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer. Urol Oncol (2007) 0.97
A phase I trial of docetaxel/estramustine/imatinib in patients with hormone-refractory prostate cancer. Clin Genitourin Cancer (2007) 0.96
Relationship of imaging frequency and planning margin to account for intrafraction prostate motion: analysis based on real-time monitoring data. Int J Radiat Oncol Biol Phys (2012) 0.95
Method to account for dose fractionation in analysis of IMRT plans: modified equivalent uniform dose. Int J Radiat Oncol Biol Phys (2005) 0.95
Self-inactivating lentiviral vectors resist proviral methylation but do not confer position-independent expression in hematopoietic stem cells. Mol Ther (2004) 0.94
The independent impact of extended pattern biopsy on prostate cancer stage migration. J Urol (2005) 0.94
Comparison of treatment plans using intensity-modulated radiotherapy and three-dimensional conformal radiotherapy for paranasal sinus carcinoma. Int J Radiat Oncol Biol Phys (2003) 0.93
Intrathoracic patterns of failure for non-small-cell lung cancer with positron-emission tomography/computed tomography-defined target delineation. Int J Radiat Oncol Biol Phys (2007) 0.93
A population-based atlas and clinical target volume for the head-and-neck lymph nodes. Int J Radiat Oncol Biol Phys (2004) 0.93
A new smoothing procedure to reduce delivery segments for static MLC-based IMRT planning. Med Phys (2004) 0.93